Position in NBIX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$310,450
+$83,331 QoQ
Shares Held
1,842
+6.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#535
of 768 holders
Holding Since
Dec 2022
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LBP AM SA holds $1,345,345 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (23.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,910 | $1,034,895 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
1,842 | $310,450 |
All Filings in NBIX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $310,450 | 1,842 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $227,119 | 1,724 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $224,091 | 1,580 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $325,260 | 2,317 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $291,223 | 2,317 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $256,260 | 2,317 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $3,430,654 | 25,133 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $3,441,160 | 29,866 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $961,349 | 6,983 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $910,272 | 6,600 | Shares | Sole | 2024-05-16 | |
| 2022-12-31 | $217,380 | 1,820 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||